- Home
- SNX vs ASND Comparison
SNX vs ASND Comparison
Compare SNX & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SNX | ASND |
|---|---|---|
| Founded | 1980 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3B | 12.2B |
| IPO Year | 2003 | 2015 |
Fundamental Metrics
Financial Performance| Metric | SNX | ASND |
|---|---|---|
| Price | $154.90 | $205.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 15 |
| Target Price | $169.00 | ★ $256.27 |
| AVG Volume (30 Days) | 543.1K | ★ 640.2K |
| Earning Date | 01-09-2026 | 11-12-2025 |
| Dividend Yield | ★ 1.14% | N/A |
| EPS Growth | ★ 18.98 | N/A |
| EPS | ★ 9.21 | N/A |
| Revenue | ★ $60,973,509,000.00 | $758,592,045.00 |
| Revenue This Year | $7.25 | $99.74 |
| Revenue Next Year | $4.50 | $79.40 |
| P/E Ratio | $16.81 | ★ N/A |
| Revenue Growth | 6.94 | ★ 97.46 |
| 52 Week Low | $92.23 | $118.03 |
| 52 Week High | $167.76 | $223.19 |
Technical Indicators
Market Signals| Indicator | SNX | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 56.68 | 49.03 |
| Support Level | $151.22 | $198.30 |
| Resistance Level | $156.67 | $218.50 |
| Average True Range (ATR) | 3.49 | 9.16 |
| MACD | 0.88 | -0.64 |
| Stochastic Oscillator | 87.72 | 28.05 |
Price Performance
Historical ComparisonAbout SNX TD SYNNEX Corporation
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.